Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Location
Missouri
St. Louis
Trial of 225Ac-DOTATATE (RYZ101) in Subjects with ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
Apply
225Ac-DOTATATE
Trial of 225Ac-DOTATATE (RYZ101) in Subjects with ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step